Objective: To evaluate the effect of splenectomy, in patients with beta thalassaemia major, on blood transfusion rates and blood counts Methodology:In this prospective descriptive study patients with beta thalassaemia major, who underwent splenectomy were included. The study was conducted at deptof thalassaemia, Pakistan Institute of Medical Sciences, Islamabad from January 2018 to December 2018. Thalasseamics with signs of growth retardation, poor health, leucopenia, thrombocytopenia, increased transfusion demand (more than 250 ml/kg/year or more than four transfusions per month) or respiratory embarrassment (mechanical discomfort) from massive splenomegaly were included. The pre- and post-splenectomy transfusion requirement was calculated by dividing the volume of packed red cells used for transfusion in one year by the patient's weight at mid-year and expressing the result as ml/kg/year.Hypersplenism was established in patients having splenomegaly with accompanying anaemia, leucopenia, thrombocytopenia or any combination of these with hypercellular bone marrow. Results: The majority were male (60.65%). The average hospital stay was six days. Pre-splenectmy, majority of patients had transfusion requirements of more than 350 ml/kg/l. Blood tranfusion requirements revealed a significant fall (less than 250 ml/kg/l) post splenectomy. One year follow up showed significant fall in transfusion rateand significant increase in haemoglobin. In 23.94% of patients, splenectomy was performed at an age less than ten years old. Conclusion:Splenectomy has a positive outcome on blood transfusion rates and haemoglobin levels in patients with beta thalassaemia major.